FDA establishment 3005757050, Solan, India. Part of Glenmark Pharmaceuticals's FDA records. Every inspection FDA has posted for the site, with its outcome and cited regulations, and the shipments FDA refused at the border.
FY2018 to FY2027 to date; 1 classified OAI
A hatched bar is a year that is not over, so its count covers only part of the year.
Inspections citing each reference
| Ended | Product and area | Citations | Classification |
|---|---|---|---|
| Jun 22, 2022 | Drugs · Drug Quality Assurance | 6 cited references
| Official Action Indicated (OAI) |
| Sep 21, 2018 | Drugs · Drug Quality Assurance | None posted | No Action Indicated (NAI) |
| Nov 11, 2017 | Drugs · Drug Quality Assurance | 7 cited references
| Voluntary Action Indicated (VAI) |
| May 29, 2015 | Drugs · Drug Quality Assurance | None posted | Voluntary Action Indicated (VAI) |
| Aug 24, 2012 | Drugs · Drug Quality Assurance | None posted | No Action Indicated (NAI) |
| Nov 13, 2009 | Drugs · Drug Quality Assurance | None posted | Voluntary Action Indicated (VAI) |
| Product | Charges | Latest |
|---|---|---|
| TELMISARTAN (ANTI-HYPERTENSIVE - PART II)Drugs · 62ODY09 | Oct 23, 20267 lines | |
| SIBUTRAMINE HCL MONOHYDRATE (ANOREXIC)Drugs · 60RCY19 | Oct 22, 2026 | |
| MOMETASONE FUROATE (ANTI-INFECTIVE, TOPICAL)Drugs · 62FCY53 | Oct 9, 2026 | |
| TACROLIMUS (IMMUNOSUPPRESSIVE)Drugs · 64TCY08 | Oct 9, 2026 | |
| DEXTROMETHORPHAN HYDROBROMIDE (ANTI-TUSSIVE/COLD)Drugs · 62UDL11 | Oct 9, 2026 | |
| TELMISARTAN (ANTI-HYPERTENSIVE - PART II)Drugs · 62OCY09 | Oct 8, 20262 lines | |
| CLOTRIMAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC)Drugs · 61WDY04 | Sep 30, 2026 | |
| METRONIDAZOLE (ANTI-PROTOZOAL, A-LEISHMANIAL, A-MALARIAL)Drugs · 62LCA40 | Sep 25, 2026 | |
| TELMISARTAN (ANTI-HYPERTENSIVE - PART II)Drugs · 62OCA09 | Sep 24, 2026 | |
| ANTI-INFLAMMATORY N.E.C.Drugs · 62GDY99 | Sep 14, 2026 | |
| VITAMIN, N.E.C.Foods · 54AGA99 | Sep 14, 2026 | |
| ANTI-INFLAMMATORY N.E.C.Drugs · 62GDA99 | Sep 14, 2026 | |
| CLOXACILLIN SODIUM (PENICILLIN, SYNTHETICALLY PRODUCED)Drugs · 56BDY15 | Sep 14, 2026 | |
| DOXYCYCLINE (TETRACYCLINES)Drugs · 56EDY20 | Sep 8, 2026 | |
| GUAIFENESIN (EXPECTORANT)Drugs · 64HDY02 | Aug 25, 20263 lines | |
| EXPECTORANT N.E.C.Drugs · 64HDL99 | Aug 25, 2026 | |
| TELMISARTAN (ANTI-HYPERTENSIVE - PART II)Drugs · 62OCA09 | Aug 19, 20264 lines | |
| TELMISARTAN (ANTI-HYPERTENSIVE - PART II)Drugs · 62ODY09 | Aug 14, 20263 lines | |
| GUAIFENESIN (EXPECTORANT)Drugs · 64HDL02 | Aug 11, 2026 | |
| CLOTRIMAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC)Drugs · 61WDO04 | Aug 3, 2026 | |
| CLOTRIMAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC)Drugs · 61WCY04 | Jul 24, 2026 | |
| TELMISARTAN (ANTI-HYPERTENSIVE - PART II)Drugs · 62OCB09 | Jun 22, 2026 | |
| HALOBETASOL PROPIONATE (GLUCOCORTICOID)Drugs · 64LDO69 | May 27, 2026 | |
| ANTI-RHEUMATIC N.E.C.Drugs · 62QDA99 | May 15, 2026 | |
| MISCELLANEOUS PATENT MEDICINES, ETC.Drugs · 66VIY99 | Feb 10, 20262 lines | |
| CLOTRIMAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC)Drugs · 61WDJ04 | Feb 6, 2026 | |
| BANDAGE, ELASTICDevices · 80FQM | Jan 2, 2026 | |
| ANTI-HYPERTENSIVE N.E.C.Drugs · 62CDA99 | Dec 22, 2025 | |
| ANTIFUNGAL N.E.C.Drugs · 56GDY99 | Aug 27, 2025 | |
| ITRACONAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC)Drugs · 61WCE46 | Aug 27, 2025 | |
| MOMETASONE FUROATE (ANTI-INFECTIVE, TOPICAL)Drugs · 62FCO53 | Aug 1, 2025 | |
| TELMISARTAN (ANTI-HYPERTENSIVE - PART II)Drugs · 62OCH09 | Aug 1, 2025 | |
| TITANIUM DIOXIDE (PROTECTANT)Drugs · 65LDA11 | Aug 1, 2025 | |
| TELMISARTAN (ANTI-HYPERTENSIVE - PART II)Drugs · 62ODA09 | May 2, 2025 | |
| EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.Drugs · 66YDY99 | Feb 24, 2025 | |
| TELMISARTAN (ANTI-HYPERTENSIVE - PART II)Drugs · 62ODA09 | Jan 22, 2025 | |
| ANTI-PSORIATIC N.E.C.Drugs · 62NCA99 | Dec 6, 2024 | |
| ITRACONAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC)Drugs · 61WCH46 | Dec 3, 2024 | |
| ITRACONAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC)Drugs · 61WCY46 | Dec 2, 2024 | |
| CLOTRIMAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC)Drugs · 61WDJ04 | Nov 14, 20242 lines | |
| CLOTRIMAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC)Drugs · 61WDL04 | Oct 24, 2024 | |
| ANTI-RHEUMATIC N.E.C.Drugs · 62QDY99 | Oct 8, 2024 | |
| MOMETASONE FUROATE (ANTI-INFECTIVE, TOPICAL)Drugs · 62FDY53 | Sep 26, 2024 | |
| ADAPALENE (ANTI-SEBORRHEIC)Drugs · 62SDY02 | Sep 17, 2024 | |
| TELMISARTAN (ANTI-HYPERTENSIVE - PART II)Drugs · 62OCY09 | Aug 21, 2024 | |
| ITRACONAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC)Drugs · 61WCY46 | Aug 16, 2024 | |
| MISCELLANEOUS PATENT MEDICINES, ETC.Drugs · 66VCY99 | May 10, 2024 | |
| MISCELLANEOUS PATENT MEDICINES, ETC.Drugs · 66VCY99 | Apr 25, 2024 | |
| FENOFIBRATE (ANTI-CHOLESTEREMIC)Drugs · 61JDA09 | Jan 19, 2024 |
An FEI (FDA Establishment Identifier) names one physical site. Inspections, outcomes and citations come from FDA's Data Dashboard; FDA posts citations only for some inspections. A contract site can make products for many companies, so the company shown is the one FDA lists as the site's firm. FDA Data Dashboard and warning letters